Illustrative scenario

Accelerate Database Lock and Cut External CDM Costs With an AI Data Management Agent

For a Head of Biostatistics and Data Management at a biotech, every week of delay between last patient last visit and database lock is a week added to your regulatory timeline. The work between those two points — cleaning queries, SDTM domain mapping, DQ checks against define.xml — is methodical, high-stakes, and heavily dependent on an external CDM vendor that bills by the hour.

Up and running in ~10 wkFor: Head of Biostatistics & Data Management, biotech
Estimate your payback
~4 mo
Payback period
$6.5M
Est. savings / year
+$4.5M
Year-1 net

Rough estimate — change the numbers to match your business. We scope the real figures with you on a call.

The Bottleneck Between Data Collection and Database Lock

Clinical data management under CDISC standards is technically demanding but procedurally repetitive. Data cleaning queries flow through Jira; SAS log reviews surface DQ issues; SDTM mapping specifications need to be generated from ODM and EDC metadata and reconciled against CDISC define.xml requirements for every domain. At $1M–$10M per trial in CDM costs, the external vendor relationship is one of the largest line items in the clinical operations budget — and the timeline dependency means delays in CDM deliverables directly push out your NDA or BLA submission date.

How an AI Agent Handles the SDTM Mapping Workflow

An AI Labor Company agent integrates with the Jira-based data cleaning query workflows and SAS log review processes your DM team already uses. It deploys agents to auto-generate SDTM mapping specifications from ODM and EDC metadata, then run DQ checks against your CDISC define.xml to surface issues before they reach the Statistical Programmer review. Each domain map is reviewed and approved by the Statistical Programmer lead before database lock — the agent accelerates the generation and validation cycle, but the qualified signoff stays where it belongs. ADaM dataset derivation specifications can be scoped as part of the implementation.

The Business Case: Three Weeks Earlier and 35% Less to Vendors

Database lock acceleration of approximately 3 weeks per trial is a direct regulatory timeline benefit — and for a biotech with a drug in late-stage development, that has real strategic value. The external CDM vendor cost reduction is illustratively around 35% annually, driven by shifting the SDTM spec generation, DQ check, and mapping review work to the agent. Workflow efficiency on the specific tasks being automated is in the 55–75% illustrative range. Most biotech teams are live and running automated SDTM mapping workflows within about 10 weeks of implementation.

Questions

Does the agent replace the Statistical Programmer, or support them?

The agent handles SDTM spec generation, DQ checks, and define.xml validation — the time-consuming production work. The Statistical Programmer lead reviews and approves every domain map before database lock. The programmer's judgment and sign-off remain essential.

Which EDC systems can the agent pull ODM metadata from?

The specific EDC integration (Medidata Rave, Veeva Vault EDC, Oracle Clinical One, etc.) is configured during implementation based on your trial's stack. ODM-standard exports are the primary ingestion path.

Can the agent also handle ADaM dataset mapping, or only SDTM?

SDTM mapping and DQ validation are the core use case. ADaM derivation specification support can be scoped as part of the implementation conversation depending on your program's needs.

Related use cases

Illustrative scenario for healthcare, pharma & life sciences. Figures are example ranges, not guarantees — we scope real numbers with you on a call.

Want this running in your business?

We'll scope an agent for this on a free 15-minute call.

Book a free call